Viking Therapeutics (VKTX) Times Interest Earned (2014 - 2015)

Viking Therapeutics has reported Times Interest Earned for 13 years, with the latest figure at -$1.01 in Q2 2026.

• Quarterly Times Interest Earned fell 3.98% year-over-year to -$1.01 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.27 (down 53.87% YoY) and the FY2025 annual result came in at -$3.45, down 275.17% from the prior year.
• Times Interest Earned rose to -$1.01 in Q2 2026 per VKTX's latest filing, from -$1.62 in the prior quarter.
• Over five years, Times Interest Earned peaked at -$0.0 in Q1 2023 and troughed at -$9.84 in Q2 2022.
• A 5-year average of -$2.08 and a median of -$0.9 in 2025 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2023 and 2024: Times Interest Earned soared 100.0% in 2023, then plunged 31826.29% in 2024.
• Over 5 years, Times Interest Earned stood at -$0.99 in 2022, then surged by 52.39% to -$0.47 in 2023, then soared by 40.14% to -$0.28 in 2024, then tumbled by 412.86% to -$1.45 in 2025, then grew by 29.96% to -$1.01 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$1.01, -$1.62, and -$1.45 for Q2 2026, Q1 2026, and Q4 2025 respectively.